varenicline has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benson, LR; Bhatti, BS; Breining, SR; Byrd, GD; Fedorov, NB; Hepler, CD; Hooker, DN; Kiser, MN; Lucero, LM; Lukas, RJ; Melvin, M; Mitchener, JP; Reynolds, LA; Sidach, SS; Whiteaker, P; Yohannes, D; Zhang, J | 1 |
| Brunner, D; Eaton, JB; Fedolak, A; Hanania, T; Kozikowski, AP; Lukas, RJ; Yu, LF; Zhang, HK | 1 |
2 other study(ies) available for varenicline and Neuroblastoma
| Article | Year |
|---|---|
Structure-activity studies of 7-heteroaryl-3-azabicyclo[3.3.1]non-6-enes: a novel class of highly potent nicotinic receptor ligands.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cells, Cultured; Electrophysiology; Humans; Kidney; Ligands; Molecular Structure; Neuroblastoma; Nicotine; Protein Subunits; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship | 2012 |
Discovery of highly potent and selective α4β2-nicotinic acetylcholine receptor (nAChR) partial agonists containing an isoxazolylpyridine ether scaffold that demonstrate antidepressant-like activity. Part II.
Topics: Animals; Antidepressive Agents; Humans; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Motor Activity; Neuroblastoma; Nicotinic Agonists; Protein Binding; Radioligand Assay; Receptors, Nicotinic; Stereoisomerism; Structure-Activity Relationship; Swimming | 2012 |